Actualización sobre infección por Clostridium difficile en el paciente mayor

Donskey, 2017, Clostridium difficile in older adults, Infect Dis Clin N Am., 31, 743, 10.1016/j.idc.2017.07.003 Leffler, 2015, Clostridium difficile infection, N Engl J Med., 372, 1539, 10.1056/NEJMra1403772 Lawson, 2016, Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938, Anaerobe., 40, 95, 10.1016/j.anaerobe.2016.06.008 García-Sánchez, 2016, El microbiólogo clínico ante los cambios taxonómicos en el género Clostridium, Rev Esp Quimioter., 29, 239 Asensio, 2013, Cost of Clostridium difficile associated diarrhea in Spain, Rev Esp Salud Publica., 87, 25, 10.4321/S1135-57272013000100004 Asensio, 2015, The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study, Int J Infect Dis., 36, 31, 10.1016/j.ijid.2015.05.013 Rea, 2012, Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota, J Clin Microbiol., 50, 867, 10.1128/JCM.05176-11 Riggs, 2007, Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents, Clin Infect Dis., 45, 992, 10.1086/521854 Donskey, 2015, Colonization versus carriage of Clostridium difficile, Infect Dis Clin North Am., 29, 13, 10.1016/j.idc.2014.11.001 Halstead, 2019, Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission, J Hosp Infect., 102, 125, 10.1016/j.jhin.2018.10.012 Kundrapu, 2016, Response to Prior and Fitzpatrick, Infect Control Hosp Epidemiol., 37, 362, 10.1017/ice.2015.338 Curry, 2013, Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers of Clostridium difficile transmission, Clin Infect Dis., 57, 1094, 10.1093/cid/cit475 Alcalá Hernández, 2017, Infección por Clostridium difficile, Med Clin (Barc)., 148, 456, 10.1016/j.medcli.2017.01.033 Bhutto, 2008, The clinical significance of gastrointestinal changes with aging, Curr Opin Clin Nutr Metab Care., 11, 651, 10.1097/MCO.0b013e32830b5d37 Olsen, 2018, Increase age has limited impact on risk of Clostridium difficile infection in an elderly population, Open Forum Infect Dis., 5, ofy160, 10.1093/ofid/ofy160 Hopkins, 2002, Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection, J Med Microbiol., 51, 448, 10.1099/0022-1317-51-5-448 Hengsgens, 2012, Time of interval of increased risk for Clostridium difficile infection after exposure to antibiotics, J Antimicrob Chemother., 67, 742, 10.1093/jac/dkr508 Pear, 1994, Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use, Ann Intern Med., 120, 272, 10.7326/0003-4819-120-4-199402150-00003 Lawes, 2017, Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis, Lancet Infect Dis, 17, 194, 10.1016/S1473-3099(16)30397-8 Climo, 1998, Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost, Ann Intern Med., 128, 989, 10.7326/0003-4819-128-12_Part_1-199806150-00005 Dingle, 2017, Effects of control interventions on Clostridium difficile infection in England: an observational study, Lancet Infect Dis., 17, 411, 10.1016/S1473-3099(16)30514-X Bouza, 2017, An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy, Eur J Clin Microbiol Infect Dis., 36, 1777, 10.1007/s10096-017-2991-y Carling, 2003, Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years, Infect Control Hosp Epidemiol., 24, 699, 10.1086/502278 McNulty, 1997, Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy, J Antimicrob Chemother., 40, 707, 10.1093/jac/40.5.707 Settle, 1998, Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam, Aliment Pharmacol Ther., 12, 1217, 10.1046/j.1365-2036.1998.00428.x Khan, 2003, Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital, J Hosp Infect., 54, 104, 10.1016/S0195-6701(03)00115-4 Nelson, 1994, Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins, Infect Control Hosp Epidemiol., 15, 88, 10.2307/30145537 Guh, 2018, Clostridioides difficile infection, Ann Intern Med., 169, ITC49, 10.7326/AITC201810020 McDonald, 2018, Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clin Infect Dis., 66, e1, 10.1093/cid/cix1085 Shah, 2000, Gastric acid suppression does not promote clostridial diarrhoea in the elderly, QJM., 93, 175, 10.1093/qjmed/93.3.175 Dial, 2005, Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease, JAMA., 294, 2989, 10.1001/jama.294.23.2989 Sahay, 2014, Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study, BMC Infect Dis., 4, 661, 10.1186/s12879-014-0661-6 Wang, 2014, Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea, Therap Adv Gastroenterol., 7, 14, 10.1177/1756283X13502838 Bauer, 2012, Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis, Clin Infect Dis., 55, S149, 10.1093/cid/cis340 Miller, 2013, Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy, BMC Infect Dis., 13, 148, 10.1186/1471-2334-13-148 Nathanson, 2017, The dangers of extreme body mass index values in patients with Clostridium difficile, Infection., 45, 787, 10.1007/s15010-017-1036-x Boone, 2018, Development of a frailty index for older adults hospitalized with clostridium difficile infection, Innov Aging., 2, 716, 10.1093/geroni/igy023.2652 Deshpande, 2015, Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis, Infect Control Hosp Epidemiol., 36, 452, 10.1017/ice.2014.88 Abou Chakra, 2014, Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review, PLoS One., 9, e98400, 10.1371/journal.pone.0098400 Garey, 2008, Meta-analysis to assess risk factors for recurrent Clostridium difficile infection, J Hosp Infect, 70, 298, 10.1016/j.jhin.2008.08.012 D’Agostino, 2014, Risk estimation for recurrent Clostridium difficile infection based on clinical factors, Clin Infect Dis., 58, 1386, 10.1093/cid/ciu107 Song, 2019, Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention, Gut Liver., 13, 16, 10.5009/gnl18071 Kyne, 2001, Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea, Lancet., 357, 189, 10.1016/S0140-6736(00)03592-3 Abou Chakra, 2012, Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review, PLoS One., 7, e30258, 10.1371/journal.pone.0030258 Goorhuis, 2008, Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078, Clin Infect Dis., 47, 1162, 10.1086/592257 Abou Chakra, 2015, Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort, Clin Infect Dis., 61, 1781, 10.1093/cid/civ749 Lamont J.T. Kelly C.P. Bakken J.S. Clostridioides (formerly Clostridium) difficile infection in adults: Clinical manifestations and diagnosis, UptoDate. [actualizado 25 Oct 2018; consultado 14 Ago 2019] Loo, 2005, A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality, N Engl J Med., 353, 2442, 10.1056/NEJMoa051639 Barra-Carrasco, 2014, Clostridium difficile spores and its relevance in the persistence and transmission of the infection, Rev Chilena Infectol., 31, 694, 10.4067/S0716-10182014000600010 Pareja Sierra, 2007, Diarrea asociada a Clostridium difficile en el paciente anciano, Rev Clin Esp., 207, 86, 10.1157/13100203 Barlett, 2002, Antibiotic-associated diarrhea, N Eng J Med., 346, 334, 10.1056/NEJMcp011603 Gateau, 2018, How to: diagnose infection caused by Clostridium difficile, Clin Microbiol Infect., 24, 463, 10.1016/j.cmi.2017.12.005 Alcalá-Hernández, 2016, Diagnóstico microbiológico de la infección por Clostridium difficile, Enferm Infecc Microbiol Clin., 34, 595, 10.1016/j.eimc.2015.09.004 Bouza, 2016, Optimizing the diagnostic testing of Clostridium difficile infection, Expert Rev Anti Infect Ther., 14, 801, 10.1080/14787210.2016.1216313 Crobach, 2016, European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection, Clin Microbiol Infect., 22, S63, 10.1016/j.cmi.2016.03.010 Cho, 2020, Update on Treatment of Clostridioides difficile Infection, Mayo Clin Proc., 95, 758, 10.1016/j.mayocp.2019.08.006 Koo, 2009, Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis, Clin Infec Dis., 48, 598, 10.1086/596711 Gerding, 2009, Antimotility agents for the treatment of Clostridium difficile: is the juice worth the squeeze?, Clin Infect Dis., 48, 606, 10.1086/596712 Debast, 2014, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clin Microbiol Infect., 20, 1, 10.1111/1469-0691.12418 Wong, 1999, Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest, Diagn Microbiol Infect Dis., 34, 1, 10.1016/S0732-8893(98)00139-4 McFarland, 2002, Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease, Am J Gastroenterol., 97, 1769, 10.1111/j.1572-0241.2002.05839.x Tedesco, 1985, Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis, Am J Gastroenterol., 80, 867 Hota, 2017, Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial, Clin Infect Dis., 64, 265, 10.1093/cid/ciw731 Sirbu, 2017, Vancomycin taper and pulse regimen with careful follow-up for patients with recurrent Clostridium difficile infection, Clin Infect Dis., 65, 1396, 10.1093/cid/cix529 Bakken, 2014, Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection, Clin Infect Dis., 59, 858, 10.1093/cid/ciu429 Neal, 2011, Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease, Ann Surg, 254, 423, 10.1097/SLA.0b013e31822ade48 Peprah, 2019, Comparison of outcomes between total abdominal and partial colectomy for the management of severe, complicated Clostridium difficile infection, J Am Coll Surg., 228, 925, 10.1016/j.jamcollsurg.2018.11.015 Ferrada, 2017, Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile-associated disease: An Eastern Association for the Surgery of Trauma multicenter trial, J Trauma Acute Care Surg., 83, 36, 10.1097/TA.0000000000001498 Nelson, 2017, Antibiotic treatment for Clostridium difficile associated diarrhoea in adults, Cochrane Database Syst Rev., 3, CD004610 Carignan, 2016, Efficacy of secondary prophylaxis with vancomycin for preventing recurrent Clostridium difficile infections, Am J Gastroenterol., 111, 1834, 10.1038/ajg.2016.417 Kelly, 2019, Clostridioides (formerly Clostridium) difficile infection in adults: Treatment and prevention, UptoDate. Wilcox, 1995, Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin, J Antimicrob Chemother., 36, 673, 10.1093/jac/36.4.673 Louie, 2006, Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea, Clin Infect Dis., 43, 411, 10.1086/506349 Zar, 2007, A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity, Clin Infect Dis., 45, 302, 10.1086/519265 Johnson, 2014, Vancomycin, metronidazole, or tolevamer for Clostridium difficile Infection: Results from two multinational, randomized, controlled trials, Clin Infecti Dis., 59, 345, 10.1093/cid/ciu313 Musher, 2005, Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole, Clin Infect Dis., 40, 1586, 10.1086/430311 Asempa, 2017, Clostridium difficile infection in the elderly: an uptodate on management, Clin Interv Aging., 12, 1799, 10.2147/CIA.S149089 Vardakas, 2012, Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systemic review of the evidence, Int J Antimicrob Agents., 40, 1, 10.1016/j.ijantimicag.2012.01.004 Cober, 2009, Clostridium difficile infection in the “oldest» old: clinical outcomes in patients aged 80 and older, J Am Geriatruc Soc., 57, 659, 10.1111/j.1532-5415.2009.02182.x Fernandez, 2004, Factors associated with failure of metronidazole in Clostridium difficile-associated disease, J Clin Gastroenterol., 38, 414, 10.1097/00004836-200405000-00005 Bolton, 1986, Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile, Gut., 27, 1169, 10.1136/gut.27.10.1169 Hu, 2008, A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection, Clin Gastroenterol Hepatol., 6, 1354, 10.1016/j.cgh.2008.06.024 Louie, 2013, Effect of age on treatment outcomes in Clostridium difficile infection, J Am Geriatr Soc., 61, 222, 10.1111/jgs.12090 Yamamoto, 2012, Metronidazole-induced neurotoxicity developed in liver cirrhosis, J Clin Med Res., 4, 295 Cunha, 2018, Enhanced efficacy of high dose oral vancomycin therapy in Clostridium difficile diarrhea for hospitalized adults not responsive to conventional oral vancomycin therapy: antibiotic stewardship implications, J Clin Med., 7, E75, 10.3390/jcm7040075 Venugopal, 2012, Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection, Clin Infect Dis., 54, 568, 10.1093/cid/cir830 Housman, 2016, Assessment of Clostridium difficile burden in patients over time with first episode infection following fidaxomicin or vancomycin, Infect Control Hosp Epidemiol., 37, 215, 10.1017/ice.2015.270 Crook, 2012, Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials, Clin Infect Dis., 55, S93, 10.1093/cid/cis499 Louie, 2011, Fidaxomicin versus vancomycin for Clostridium difficile infection, N Engl J Med., 364, 422, 10.1056/NEJMoa0910812 Apisarnthanarak, 2002, Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature, Clin Infect Dis., 35, 690, 10.1086/342334 Malamood, 2015, Vancomycin enemas as adjunctive therapy for Clostridium difficile infection, J Clin Med Res., 7, 422, 10.14740/jocmr2117w Pettit, 2015, Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection, Pharmacotherapy., 35, 119, 10.1002/phar.1538 Rokas, 2015, The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile infection, Clin Infect Dis., 61, 934, 10.1093/cid/civ409 Popovic, 2018, Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study, Eur J Clin Microbiol Infect Dis., 37, 745, 10.1007/s10096-017-3169-3 Woods, 2018, Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240, Anaerobe., 53, 108, 10.1016/j.anaerobe.2018.06.013 Davido, 2017, Oral teicoplanin as an alternative first-line regimen in Clostridium difficile infection in elderly patients: a case series, Clin Drug Investig., 37, 699, 10.1007/s40261-017-0524-1 De Lalla, 1992, Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea, Antimicrob Agents Chemother., 36, 2192, 10.1128/AAC.36.10.2192 Wenisch, 1996, Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea, Clin Infect Dis., 22, 813, 10.1093/clinids/22.5.813 Vely, 2020, Role of Surgery in Clostridium difficile Infection, Clin Colon Rectal Surg., 33, 87, 10.1055/s-0040-1701232 Lamontagne, 2007, Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain, Ann Surg., 245, 267, 10.1097/01.sla.0000236628.79550.e5 Venkat, 2018, Frailty predicts morbidity and mortality after colectomy for Clostridium difficile colitis, Am Surg., 84, 628, 10.1177/000313481808400511 Cornely, 2012, Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin, Clin Infect Dis., 55, S154, 10.1093/cid/cis462 Cobo, 2018, Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score, Int J Antimicrob Agents., 51, 393, 10.1016/j.ijantimicag.2017.09.010 Beinortas, 2018, Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis, Lancet Infect Dis., 18, 1035, 10.1016/S1473-3099(18)30285-8 Cornely, 2018, Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): Analysis of cost-effectiveness, J Antimicrob Chemoter., 73, 2529, 10.1093/jac/dky184 Wilcox, 2017, Bezlotoxumab for prevention of recurrent Clostridium difficile infection, N Engl J Med., 376, 305, 10.1056/NEJMoa1602615 Yang, 2015, Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab, Infect Immun., 83, 822, 10.1128/IAI.02897-14 Alonso, 2019, Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile, Infect Drug Resist., 12, 1, 10.2147/IDR.S159957 Informe de posicionamiento terapéutico de bezlotoxumab (Zinplava®) en la prevención de la recurrencia de la infección por Clostridium difficile en adultos con alto riesgo de recurrencia. Ministerio de Sanidad. Consumo y Bienestar Social; 2018 [consultado 22 Abr 2020]. Disponible en: https://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/IPT-bezlotoxumab-Zinplava-inf-Clostridium-difficile.pdf Garey, 2011, A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection, J Antimicrob Chemother., 66, 2850, 10.1093/jac/dkr377 Major, 2019, Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial, Gut., 68, 1224, 10.1136/gutjnl-2018-316794 Zhang, 2019, Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection, BMC Infect Dis., 19, 51, 10.1186/s12879-019-3676-1 Bermejo Boixareu, 2019, Ninety-eight years old female treated with fecal microbiota transplantation after recurrent Clostridium difficile infection, Med Clin (Barc)., 153, e27, 10.1016/j.medcli.2018.11.024 Bowden, 1981, Pseudomembranous enterocolitis: mechanism for restoring floral homeostasis, Am Surg., 47, 178 Guo, 2012, Systematic review; faecal transplantation for the treatment of Clostridium difficile-associate disease, Aliment Pharmacol Ther., 35, 865, 10.1111/j.1365-2036.2012.05033.x Cammarota, 2017, European consensus conference on faecal microbiota transplantation in clinical practice, Gut., 66, 569, 10.1136/gutjnl-2016-313017 Hvas, 2019, Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection, Gastroenterology., 156, 1324, 10.1053/j.gastro.2018.12.019 Gough, 2011, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, Clin Infect Dis., 53, 994, 10.1093/cid/cir632 Friedman-Korn, 2018, Fecal transplantation for treatment of Clostridium difficile infection in elderly and debilitated patients, Dig Dis Sci., 63, 198, 10.1007/s10620-017-4833-2 Kassam, 2012, Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection, Arch Intern Med., 172, 191, 10.1001/archinte.172.2.191 Drekonja, 2015, Fecal microbiota transplantation for Clostridium difficile infection: a systematic review, Ann Intern Med, 162, 630, 10.7326/M14-2693 Burke, 2013, Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review, J Am Geriatr Soc., 61, 1394, 10.1111/jgs.12378 Anand, 2017, Effect of aging on the composition of fecal microbiota in donors for FMT and its impact on clinical outcomes, Dig Dis Sci., 62, 1002, 10.1007/s10620-017-4449-6 Lagier, 2015, Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report, Eur J Clin Microbiol Infect Dis., 34, 159, 10.1007/s10096-015-2394-x García-Fernández, 2016, Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain, Diagn Microbiol Infect Dis., 86, 470, 10.1016/j.diagmicrobio.2016.09.004 Juul, 2018, Fecal microbiota transplantation for primary Clostridium difficile infection, N Engl J Med., 378, 2535, 10.1056/NEJMc1803103 Han, 2016, Fecal microbiota transplant: treatment options for Clostridium difficile infection in the intensive care unit, J Intensive Care Med., 31, 577, 10.1177/0885066615594344 Fischer, 2015, Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate, Aliment Pharmacol Ther., 42, 470, 10.1111/apt.13290 Khoruts, 2016, Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection, Clin Gastroenterol Hepatol., 14, 1433, 10.1016/j.cgh.2016.02.018 Reigadas, 2018, Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results, Rev Esp Quimioter., 31, 411 Wang, 2019, Fecal microbiota transplantation: Review and update, J Formos Med Assoc., 118, S23, 10.1016/j.jfma.2018.08.011 Bakken, 2011, Treating Clostridium difficile infection with fecal microbiota transplantation, Clin Gastroenterol Hepatol., 9, 1044, 10.1016/j.cgh.2011.08.014 Ramai, 2019, Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness, Ann Gastroenterol, 32, 30 Davidovics, 2019, J Pediatr Gastroenterol Nutr., 68, 130, 10.1097/MPG.0000000000002205 Ramai, 2020, Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis, Dig Dis Sci., 10.1007/s10620-020-06185-7 Youngster, 2014, Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection, JAMA., 312, 1772, 10.1001/jama.2014.13875 Quraishi, 2017, Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection, Aliment Pharmacol Ther., 46, 479, 10.1111/apt.14201 Lee, 2019, Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure, Eur J Clin Microbiol Infect Dis., 38, 1731, 10.1007/s10096-019-03602-2 Kassam, 2013, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol., 108, 500, 10.1038/ajg.2013.59 DeFilipp, 2019, Drug-resistant E. coli bacteriemia transmitted by fecal microbiota transplant, N Eng J Med., 381, 2043, 10.1056/NEJMoa1910437 Tariq, 2017, Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency, Clin Infect Dis., 65, 1745, 10.1093/cid/cix618 Surawicz, 2000, The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii, Clin Infect Dis., 31, 1012, 10.1086/318130 McFarland, 1994, A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease, JAMA., 271, 1913, 10.1001/jama.1994.03510480037031 Barker, 2017, A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO), J Antimicrob Chemother., 72, 3177, 10.1093/jac/dkx254 Saha, 2019, Management of Clostridioides difficile colitis: insights for the gastroenterologist, Therap Adv Gastroenterol., 12, 10.1177/1756284819847651 Aziz, 2019, Surotomycin (a novel cyclic lipopeptide) vs. vancomycin for treatment of Clostridioides difficile infection: a systematic review and meta-analysis, Curr Clin Pharmacol., 14, 166, 10.2174/1574884714666190328162637 Banach, 2018, Duration of contact precautions for acute care settings, Infect Control Hosp Epidemiol., 39, 127, 10.1017/ice.2017.245 Dubberke, 2014, Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update, Infect Control Hosp Epidemiol., 35, 628, 10.1086/676023 Barker, 2017, On the hands of patients with Clostridium difficile: A study of spore prevalence and the effect of hand hygiene on C difficile removal, Am J Infect Control., 45, 1154, 10.1016/j.ajic.2017.03.005 Boyce, 2002, MMWR Recomm Rep., 51, 1 Jabbar, 2010, Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands, Infect Control Hosp Epidemiol., 31, 565, 10.1086/652772 Oughton, 2009, Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile, Infect Control Hosp Epidemiol., 30, 939, 10.1086/605322 Kundrapu, 2014, A randomized trial of soap and water hand wash versus alcohol hand rub for removal of Clostridium difficile spores from hands of patients, Infect Control Hosp Epidemiol., 35, 204, 10.1086/674859 Mayfield, 2000, Environmental control to reduce transmission of Clostridium difficile, Clin Infect Dis., 31, 995, 10.1086/318149 Wilcox, 2003, Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection, J Hosp Infect., 54, 109, 10.1016/S0195-6701(02)00400-0 Longtin, 2016, Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C. difficile infections: a quasi-experimental controlled study, JAMA Intern Med., 176, 796, 10.1001/jamainternmed.2016.0177 Hickson, 2007, Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial, BMJ., 335, 80, 10.1136/bmj.39231.599815.55 Lau, 2016, Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis, Int J Gen Med., 9, 27 Allen, 2013, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial, Lancet., 382, 1249, 10.1016/S0140-6736(13)61218-0 Liong, 2008, Safety of probiotics: translocation and infection, Nutr Rev., 66, 192, 10.1111/j.1753-4887.2008.00024.x Costa, 2018, Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series, BMC Complement Altern Med., 18, 329, 10.1186/s12906-018-2394-3